Other
Drug Facts
MANUFACTURED BY
Pharmaceutical Associates, Inc.
Greenville, SC 29605
R12/20
The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Docusate Sodium (NDC 0121-1870). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient (in each 5 ml), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
MANUFACTURED BY
Pharmaceutical Associates, Inc.
Greenville, SC 29605
R12/20
Docusate sodium 50 mg
Stool softener
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and older | 5 to 20 mL (1 to 4 teaspoonfuls) |
| children 6 to under 12 years of age | 5 to 10 mL (1 to 2 teaspoonfuls) |
| children 3 to under 6 years of age | 2.5 to 5 mL (1/2 to 1 teaspoonful) |
| children under 3 years | ask a doctor |
NDC 0121-0935-16: 16 fl oz (473 mL) bottle
NDC 0121-0935-05: 5 mL unit dose cup, in a tray of ten cups.
NDC 0121-1870-10: 10 mL unit dose cup, in a tray of ten cups.
artificial cherry vanilla flavoring, citric acid anhydrous, D&C Red No. 33, glycerin, methylparaben, polyethylene glycol, propylene glycol, propylparaben, purified water, saccharin sodium, sodium citrate, and sorbitol.
Call 1-800-845-8210
* Please review the disclaimer below.